Literature DB >> 25429914

Abnormal bone marrow histopathology in paediatric mastocytosis.

Melody C Carter1, Dean D Metcalfe, Alicia S Clark, Alan S Wayne, Irina Maric.   

Abstract

The diagnostic criteria for paediatric mastocytosis are largely based on adult studies and bone marrow findings are not well described in children. We evaluated use of the World Health Organization (WHO) criteria for the diagnosis of systemic disease in paediatric mastocytosis. In addition, we identified unique clinico-histopathological features within the biopsies. One hundred and thirteen children with paediatric mastocytosis were evaluated at the National Institutes of Health between 1986 and 2013. Complete bone marrow evaluations were performed in 50 cases. Seven children had repeat procedures. Bone marrows were analysed by histopathology, flow cytometry and for KIT D816V. Bone marrow biopsies displayed mild atypical haematopoietic maturation, increased haematogones and hypocellularity in a sub-set of patients with urticaria pigmentosa, diffuse cutaneous mastocytosis and indolent systemic mastocytosis. Hypocellularity was most pronounced in those with urticaria pigmentosa. Haematogones were highest, on average, in patients with diffuse cutaneous mastocytosis or mastocytomas. There was no evidence of peripheral blood cytopenias, myelodysplastic syndrome, myeloproliferative neoplasm or leukaemia within this cohort. The WHO criteria are applicable for the diagnosis of systemic mastocytosis in paediatrics. Although unsuspected bone marrow findings typically seen in myeloproliferative disorders are frequent in paediatric mastocytosis, patients within this study remained clinically stable without progression to a more aggressive variant. Published 2014. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  bone marrow; childhood; mastocytosis; myeloproliferative; paediatrics

Mesh:

Year:  2014        PMID: 25429914      PMCID: PMC9254166          DOI: 10.1111/bjh.13231

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   8.615


  23 in total

1.  Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry.

Authors:  R W McKenna; L T Washington; D B Aquino; L J Picker; S H Kroft
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

2.  Mastocytosis and atopy: a study of 33 patients with urticaria pigmentosa.

Authors:  U Müller; A Helbling; T Hunziker; B Wüthrich; A Pécoud; S Gilardi; E Beretta; J Fasel; W Messerli; P Maurer
Journal:  Allergy       Date:  1990-11       Impact factor: 13.146

3.  Epidemiology of systemic mastocytosis in Denmark.

Authors:  Sarah S Cohen; Stine Skovbo; Hanne Vestergaard; Thomas Kristensen; Michael Møller; Carsten Bindslev-Jensen; Jon P Fryzek; Sigurd Broesby-Olsen
Journal:  Br J Haematol       Date:  2014-04-25       Impact factor: 6.998

4.  Systemic mastocytosis with associated acute myeloid leukemia with t (8; 21) (q22; q22).

Authors:  V S Gadage; P S Kadam Amare; K S Galani; N Mittal
Journal:  Indian J Pathol Microbiol       Date:  2012 Jul-Sep       Impact factor: 0.740

5.  Systemic mastocytosis in a child with t(8;21) acute myeloid leukemia.

Authors:  Kris M Mahadeo; Lucia Wolgast; Christine McMahon; Peter D Cole
Journal:  Pediatr Blood Cancer       Date:  2011-02-04       Impact factor: 3.167

6.  Clinical aspects of paediatric mastocytosis: a review of 101 cases.

Authors:  M Lange; M Niedoszytko; J Renke; J Gleń; B Nedoszytko
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-11-30       Impact factor: 6.166

7.  Myelomastocytic Leukemia With t(8;21) in a 3-year-old Child.

Authors:  Stefanos Intzes; Susan Wiersma; Howard J Meyerson
Journal:  J Pediatr Hematol Oncol       Date:  2011-12       Impact factor: 1.289

8.  Comparison of mastocytosis with onset in children and adults.

Authors:  M A Middelkamp Hup; R Heide; B Tank; P G H Mulder; A P Oranje
Journal:  J Eur Acad Dermatol Venereol       Date:  2002-03       Impact factor: 6.166

9.  Cutaneous mastocytosis in children: a clinical analysis of 71 cases.

Authors:  A E Kiszewski; C Durán-Mckinster; L Orozco-Covarrubias; P Gutiérrez-Castrellón; R Ruiz-Maldonado
Journal:  J Eur Acad Dermatol Venereol       Date:  2004-05       Impact factor: 6.166

10.  KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entities.

Authors:  Irina Maric; Jamie Robyn; Dean D Metcalfe; Michael P Fay; Melody Carter; Todd Wilson; Weiming Fu; Jennifer Stoddard; Linda Scott; Marilyn Hartsell; Arnold Kirshenbaum; Cem Akin; Thomas B Nutman; Pierre Noel; Amy D Klion
Journal:  J Allergy Clin Immunol       Date:  2007-07-12       Impact factor: 10.793

View more
  1 in total

Review 1.  Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021.

Authors:  Magdalena Lange; Karin Hartmann; Melody C Carter; Frank Siebenhaar; Ivan Alvarez-Twose; Inés Torrado; Knut Brockow; Joanna Renke; Ninela Irga-Jaworska; Katarzyna Plata-Nazar; Hanna Ługowska-Umer; Justyna Czarny; Anna Belloni Fortina; Francesca Caroppo; Roman J Nowicki; Bogusław Nedoszytko; Marek Niedoszytko; Peter Valent
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.